New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study
作者:Cristina Maccallini、Marialucia Gallorini、Francesca Sisto、Atilla Akdemir、Alessandra Ammazzalorso、Barbara De Filippis、Marialuigia Fantacuzzi、Letizia Giampietro、Simone Carradori、Amelia Cataldi、Rosa Amoroso
DOI:10.1080/14756366.2021.1954918
日期:2021.1.1
piperidine-sulphonamides as potent aromatase inhibitors. Starting from the most promising compounds, here we have synthesised new indazole and triazole derivatives and evaluated their biological activity as potential dual agents, targeting both the aromatase and the inducible nitric oxide synthase, being this last dysregulated in breast cancer. Furthermore, selected compounds were evaluated as antiproliferative
抽象的 非甾体芳香酶抑制剂(NSAI)是治疗乳腺癌的成熟药物。然而,它们表现出一些严重的副作用,并且它们的功效可能因化学耐药性的发展而受到影响。之前,我们报道了不同的吲唑基氨基甲酸酯和哌啶磺酰胺作为有效的芳香酶抑制剂。从最有前途的化合物开始,我们合成了新的吲唑和三唑衍生物,并评估了它们作为潜在双重药物的生物活性,针对芳香酶和诱导型一氧化氮合酶,这是乳腺癌中最后一个失调的酶。此外,选定的化合物在 MCF-7 细胞系中作为抗增殖剂和细胞毒剂进行了评估。此外,考虑到唑类化合物的治疗多样性,所有合成的化合物也被评估为不同念珠菌菌株的抗真菌作用。进行了对接研究以及分子动力学模拟,以阐明最有趣的化合物与不同目标酶催化位点的结合模式。